Development and Evaluation of 'My Voice': A Randomized Controlled Trial (NCT06090734) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Development and Evaluation of 'My Voice': A Randomized Controlled Trial
Singapore244 participantsStarted 2024-03-07
Plain-language summary
The study aims to develop and evaluate a web-based interactive platform (called 'My Voice') that helps to educate patients with heart failure and their caregivers about heart failure, identify their goals for end-of-life care, and share these with their caregivers and doctors.
Who can participate
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age ≥ 21 years old
. Singaporean or Permanent Resident
. Diagnosed with heart failure
. Symptoms classified under NYHA class II (with an ejection fraction of less than or equal to 35%), III or IV
. Intact cognition determined through the Abbreviated Mental Test (AMT) (for pilot testing and main RCT)
. Ability to speak and read English, Mandarin or Malay
. Willing to complete a web intervention
. Easily contactable via mobile phone or landline
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of patients who have ACP discussions with their treating doctor at least once during the study period
Timeframe: 1 year from data collection
2
Proportion of patients who have ACP discussions with their caregivers
Timeframe: 1 year from data collection
3
Proportion of patients who prefer life-extending treatments